Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Curasan

Curasan?uq=UG6efJS6
1988 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
CUR STOCK SYMBOL
1 INVESTMENTS
$0.98 SHARE PRICE (As of Friday Closing)
Description

Developer of regenerative medicines and applications. The company's regenerative medicines and applications include dental implants, bone and tissue regeneration, tissue engineering and wound healing for dental, spinal and orthopedic applications, enabling oral surgeons, general dentists, periodontists and endodontists to effectively utilize these products for orthopedics, traumatology, spine surgery and dental implantology.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
ETR
Primary Office
  • Lindigstra├če 4
  • 63801 Kleinostheim
  • Germany

+49 06027 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Curasan’s full profile, request a free trial.

Curasan Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.98 - $1.58 $16.7M $1.00 -$0.37 20.7K 16.7M

Curasan Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 21,796 21,796 11,932 8,480
Revenue 7,663 7,663 7,194 6,233
EBITDA (2,500) (2,500) (2,372) 2,062
Net Income (4,509) (4,509) (2,306) 1,479
Total Assets 17,453 17,453 13,266 13,750
Total Debt 318 318 2 11
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Curasan Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Curasan‘s full profile, request access.

Request full access to PitchBook

Curasan Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 18-Mar-2013 000000000000000000 Medical Supplies
To view this company’s complete investment and acquisition history, request access »

Curasan Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Curasan‘s full profile, request access.

Request full access to PitchBook

Curasan Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Schlenk Chief Executive Officer
Christine Uekert Chief Financial Officer